compounding pharmacy glp-1 fda enforcement news today Undercutting HHS Secretary Robert F. Kennedy Jr.'s recent push to expand access to peptides, career scientists determined there isn't adequate evidence to support any of the ones under consideration for production FDA cracks down on 'misleading'

WATCH | What WHO's move to back obesity drugs means: What could approval mean for patients Canadians taking GLP-1 medicatiosn for weight loss pay anywhere from $200 to $400 a month, usually out of pocket as many Canadian insurance companies don't cover the medications for obesity

Adults with a BMI of 27 kg/m squared or greater plus at least one weight-related comorbidity hypertension, dyslipidemia, prediabetes, Type 2 diabetes, or obstructive sleep apnea

Diabetes researchers at Vanderbilt University Medical Center are testing a new drug, which is derived from the saliva of the Gila monster

Application: For use in controlled laboratory and experimental settings